Echocardiography plays a unique role in the assessment of tricuspid and pulmonic valve disease. Although the tricuspid and pulmonic valves are structurally similar to the mitral and aortic valves, they rarely undergo the chronic degenerative changes that affect their left-sided counterparts. Newer and less invasive therapeutic options for treating tricuspid and pulmonic valve disease, including percutaneous valve replacement, balloon valvuloplasty, valve-in-valve replacement procedures, and, in the near future, percutaneous right-sided valve repair procedures, have increased the demand for more accurate and precise echocardiographic assessment of tricuspid and pulmonic valve disease. Three-dimensional (3D) echocardiography with concomitant 3D printing of the tricuspid and pulmonic valves, in particular, shows great promise in advancing the field of diagnostic and therapeutic options for treating right-sided valve disease, which should grow as the population ages.